Corporate Announcement
Security Code : 524804    Company : AUROPHARMA    
 
USFDA Classifies The Inspection Of Aurobindo'S API/ Intermediates Facilities Of Unit I, IX And XI As OAIDownload PDFDownload XBRL
  Exchange Received Time  17/05/2019 09:09:40         Exchange Disseminated Time   17/05/2019 09:09:49              Time Taken   00:00:09
This is to inform that the Company has received letters from the USFDA classifying the inspections concluded at our API facilities of Unit I and XI and intermediates facility of unit IX in February 2019 as Official Action Indicated (OAI).

The Company has already submitted its initial response to USFDA. The Company is sending further updates on the committed corrective actions.

The Company is confident that these OAI classifications will not have an impact on disruption of supplies or the revenue from operations of these facilities.

Please take the information on record.
 

Disclaimer

Back To Announcements